ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Phoenix, AZ

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Phoenix, AZ, USA:

Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies

Phase 1 Safety and Tolerability Study in Subjects with Pancreatic Cancer or Other CA19-9 Positive Malignancies....

Active, not recruiting
Pancreatic Cancer
Drug: gemcitabine + nab-paclitaxel
Drug: MVT-5873

Phase 1

BioNTech
BioNTech

Scottsdale, Arizona, United States and 4 other locations

drugs, Vemurafenib and Sorafenib, in individuals with KRAS mutated pancreatic cancer who have progressed on standard chemotherapy....

Active, not recruiting
Pancreas Cancer
Drug: Sorafenib
Drug: Vemurafenib

Phase 2

HonorHealth Research Institute

Scottsdale, Arizona, United States

A) vs. mFOLFIRINOX plus placebo (Arm B) in 94 subjects with advanced pancreatic cancer, not amenable to curative treatment. Both ar...

Active, not recruiting
Pancreatic Cancer
Drug: Ramucirumab
Other: Placebo

Phase 2

Walid Shaib, MD

Scottsdale, Arizona, United States and 7 other locations

This study will evaluate the safety and tolerability of escalating doses of L-DOS47 in combination with doxorubicin, as well as preliminary anti-tumor...

Enrolling
Pancreas Cancer
Biological: L-DOS47
Drug: Doxorubicin

Phase 1, Phase 2

Helix BioPharma

Scottsdale, Arizona, United States and 2 other locations

A Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with KRAS muta...

Enrolling
Stage III Non-small Cell Lung Cancer
Stage III Pancreatic Cancer
Drug: BMF-219

Phase 1

Biomea Fusion

Goodyear, Arizona, United States and 22 other locations

This is a Phase 1b/2, open-label, multi-center, competitive enrollment and dose-escalation study of HCW9218 in patients with advanced/metastatic pancreatic...

Active, not recruiting
Advanced Pancreatic Carcinoma
Drug: HCW9218

Phase 1, Phase 2

HCW Biologics

Scottsdale, Arizona, United States and 4 other locations

compared to just chemotherapy alone in participants with metastatic pancreatic cancer. One group of participants will only receive ...

Enrolling
Metastatic Pancreatic Ductal Adenocarcinoma
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 2

Agenus
Agenus

Scottsdale, Arizona, United States and 35 other locations

PK, and PD of SON-DP in participants with relapsed/refractory/intolerant to standard of care therapies, for advanced/ metastatic solid tumors...

Enrolling
Solid Tumor
Breast Cancer
Drug: SON-DP

Phase 1

Qurgen

Gilbert, Arizona, United States and 4 other locations

to participants. Part C will use the information from Parts A and B to see if PF-08046049/SGN-BB228 is safe and if it works to treat solid tumor...

Enrolling
Non-small Cell Lung Cancer
Colorectal Neoplasms
Drug: PF-08046049

Phase 1

Seagen
Seagen

Phoenix, Arizona, United States and 21 other locations

The goal of this study is to test A2B530,an autologous logic-gated Tmod™ CAR T-cell product in subjects with solid tumors including colorect ...

Enrolling
Solid Tumor
Non Small Cell Lung Cancer Recurrent
Biological: A2B530
Diagnostic Test: xT-Onco with HLA-LOH Assay

Phase 1, Phase 2

A2 Biotherapeutics

Gilbert, Arizona, United States of America and 9 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems